49 related articles for article (PubMed ID: 4684304)
1. Serum 25-hydroxycalciferol concentrations in normal subjects and in haemodialysed patients with chronic renal failure.
Kálmán J; Gömöri A; Juhász J; Szücs J
Int Urol Nephrol; 1980; 12(3):257-62. PubMed ID: 7251291
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bone histology in 38 patients with advanced renal failure.
Eastwood JB
J Clin Pathol; 1982 Feb; 35(2):125-34. PubMed ID: 7068905
[TBL] [Abstract][Full Text] [Related]
3. Bone disease after jejuno-ileal bypass for morbid obesity.
Gilmore IT; Eastwood JB; Ellis WR; Luck VA; Fenton S; O'Grady AJ; Harris E; Murray-Lyon IM
Postgrad Med J; 1983 May; 59(691):299-303. PubMed ID: 6878100
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat.
Parfitt AM; Mathews CH; Brommage R; Jarnagin K; DeLuca HF
J Clin Invest; 1984 Feb; 73(2):576-86. PubMed ID: 6546577
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of bilateral nephrectomy.
Catto GR; Muirhead N
Br Med J (Clin Res Ed); 1984 Jul; 289(6438):146-7. PubMed ID: 6430386
[No Abstract] [Full Text] [Related]
6. Comparison of 1,25-, 25-, and 24,25-hydroxylated vitamin D3 binding in fetal rat calvariae and osteogenic sarcoma cells.
Manolagas SC; Deftos LJ
Calcif Tissue Int; 1981; 33(6):655-61. PubMed ID: 6275969
[No Abstract] [Full Text] [Related]
7. Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.
Coburn JW; Hartenbower DL; Norman AW
West J Med; 1974 Jul; 121(1):22-44. PubMed ID: 4365934
[TBL] [Abstract][Full Text] [Related]
8. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
[No Abstract] [Full Text] [Related]
9. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
[TBL] [Abstract][Full Text] [Related]
10. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
Ritz E; Kreusser W; Boland R; Bommer J
Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficient states. Pathophysiology and treatment.
Jacobs MD
West J Med; 1979 Oct; 131(4):305-12. PubMed ID: 388869
[No Abstract] [Full Text] [Related]
12. [Quantitative histological study of osteoclastic resorption in primary and secondary hyperparathyroidism].
Meunier P; Vignon G; Vauzelle JL; Zech P
Pathol Biol (Paris); 1969 Nov; 17(21):927-38. PubMed ID: 4907648
[No Abstract] [Full Text] [Related]
13. The measurement of periosteocytic enlargement in primary and secondary hyperparathyroidism.
Meunier P; Bernard J; Vignon G
Isr J Med Sci; 1971 Mar; 7(3):482-5. PubMed ID: 5567523
[No Abstract] [Full Text] [Related]
14. The role of vitamin D in mild to moderate chronic kidney disease.
Friedman TC; Norris KC
Trends Endocrinol Metab; 2002 Jul; 13(5):189-94. PubMed ID: 12185664
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and metabolic bone disease: a clinicopathologic overview.
Felsenfeld A; Llach F
Pathol Annu; 1982; 17 (Pt 1)():383-410. PubMed ID: 6750537
[No Abstract] [Full Text] [Related]
16. Lack of histological evidence of vitamin D abnormality in the bones of anephric patients.
Bordier PJ; Chot ST; Eastwood JB; Fournier A; de Wardener HE
Clin Sci; 1973 Jan; 44(1):33-41. PubMed ID: 4684304
[No Abstract] [Full Text] [Related]
17. Metabolic bone disease in patients on maintenance hemodialysis.
Ritz E; Malluche H; Bommer J; Mehls O; Krempien B
Nephron; 1974; 12(5):393-404. PubMed ID: 4824048
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
